The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation

BACKGROUND: The toxicity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is less than that of cytotoxic agents. The reports of dramatic response and improvement in performance status with the use of EGFR TKIs may influence a physician’s decision-making for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsia, Te-Chun, Tu, Chih-Yen, Chen, Hung-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105103/
https://www.ncbi.nlm.nih.gov/pubmed/25050082
http://dx.doi.org/10.1186/1471-2253-14-55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105103/
https://www.ncbi.nlm.nih.gov/pubmed/25050082
http://dx.doi.org/10.1186/1471-2253-14-55

Ejemplares similares